Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies
about
The myth of schizophrenia as a progressive brain diseaseChanges in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychosesNicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus.Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort.Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study.Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary studyDo GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder?Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosisAbsence of practice effects in preclinical Alzheimer's disease.Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in SchizophreniaTest-retest reliability and effects of repeated testing and satiety on performance of an Emotional Test Battery.The course of cognitive functioning over six months in individuals at clinical high risk for psychosisCognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients.Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials.Differential long-term effects of haloperidol and risperidone on the acquisition and performance of tasks of spatial working and short-term memory and sustained attention in rats.Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum.Targeting cognitive deficits in schizophrenia: a review of the development of a new class of medicines from the perspective of community mental health researchers.Scoring higher the second time around: meta-analyses of practice effects in neuropsychological assessment.Clinical applications of neuropsychological assessment.Placebo Response and Practice Effects in Schizophrenia Cognition Trials.Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo.Exploring the reliability and acceptability of cognitive tests for Indigenous Australians: a pilot study.Validation of a Computerized test of Functional Capacity.Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early-onset schizophrenia patients.Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study.Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.Neuropsychological assessment of distractibility in mild traumatic brain injury and depression.Overcoming the challenge of re-assessing logical memory.Preliminary investigation of the effects of γ-tACS on working memory in schizophrenia.Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
P2860
Q24067152-6DA4EA13-DBE7-405E-80E5-2D5A1AE127E3Q28256286-C63DED6D-EB86-4F63-8F63-479DA4425714Q30470074-535B70D5-C9BD-41A9-A13D-A73D7AD271CBQ30835228-D470C6F6-F8E4-4898-9B69-819A11148336Q34048566-CA238CDF-FEF6-420D-99CF-412A9DF58D1CQ34249753-D72CB071-5073-4A1A-840C-4A1DCD8D7871Q34274859-D05619E6-FD50-4011-9637-F3853A2038C7Q34550685-FF1BE8F5-D31B-49B7-A69C-1EA02B5C0664Q35522856-FE4809AC-1779-45DD-9E2C-7A5EED38B5E6Q35915533-29A2B292-61FE-4744-93A3-F6E9C8CFD42BQ35955612-BF4BF1A7-BB53-40AE-8D7B-C27FDCD5262EQ36269046-A57E86C7-A4A8-444C-8D2E-F9C6681A0D3DQ36377916-B4DA10CE-9B97-4F1E-BA81-368268038761Q36668475-6CB72E4E-2DB9-4F2E-9FEB-F2B079EE3473Q36691885-52E6B508-745F-4D15-A41D-C4EB6ABD26EFQ36812828-8621B4CE-7BEB-46E7-93D6-62D0DA006DBAQ36926750-CDB5406A-2FDE-4522-937E-8ACE7AA41B82Q37331835-E1BD4C66-51C3-4A96-9B8F-48B9F1302D8BQ37699383-3F96D971-1423-42E9-8B17-BA54DDB51214Q37730523-6093B17D-8AAF-40CD-BD8D-B54C6A327BA5Q37953442-012AFAF6-7D08-41CA-BA7C-12BE1D8315EEQ38006006-BDA459BA-0244-4652-BD9B-5A1240BDDDB2Q38009307-A9727F83-9A95-4D9A-80C7-21F45DFBAA1AQ38715567-7E5244EF-A849-414E-B7FC-338A7EAB0C64Q39613560-F60D83B6-FD5B-4AE2-A200-995EC7E88006Q41228669-34DA64C3-F9BD-454C-BBF1-8E6215E472A4Q42121970-05F1CF64-A8E2-45E9-B8BF-8AB670DB05F2Q45194412-53839791-AE29-4873-A5F7-8F29F7DF002CQ46306395-8FC77E63-6B64-496E-896E-F35F236DFB1DQ46432285-FB26B9B0-7CB0-400E-A70E-094D3DF1D46CQ47571897-DABD7571-B522-46DF-B3D6-F6A2C75A6AF7Q47753299-0B53FA5E-BDFC-4C9B-9D9A-D1DF810CA9BBQ48429213-EFC61EC1-C240-40A1-A5D4-0B917F5E66ABQ48518204-448EC918-426C-4C33-BDDF-E44A50C6F399Q48792541-A18F5A1E-EA26-4378-BFA2-38932FD7A23DQ58561523-1595979F-B823-42CC-983C-175B8813B9BA
P2860
Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circumstances under which prac ...... to clinical treatment studies
@ast
Circumstances under which prac ...... to clinical treatment studies
@en
Circumstances under which prac ...... to clinical treatment studies
@en-gb
Circumstances under which prac ...... to clinical treatment studies
@nl
type
label
Circumstances under which prac ...... to clinical treatment studies
@ast
Circumstances under which prac ...... to clinical treatment studies
@en
Circumstances under which prac ...... to clinical treatment studies
@en-gb
Circumstances under which prac ...... to clinical treatment studies
@nl
prefLabel
Circumstances under which prac ...... to clinical treatment studies
@ast
Circumstances under which prac ...... to clinical treatment studies
@en
Circumstances under which prac ...... to clinical treatment studies
@en-gb
Circumstances under which prac ...... to clinical treatment studies
@nl
P2093
P2860
P356
P1476
Circumstances under which prac ...... to clinical treatment studies
@en
P2093
Delbert G Robinson
Richard S E Keefe
Robert S Goldman
Terry E Goldberg
P2860
P2888
P304
P356
10.1038/NPP.2009.211
P407
P577
2010-04-01T00:00:00Z
P5875
P6179
1046217866